@article{chhabra_dutt law_suri_malhotra_varma_2012, title={Methotrexate induced lung injury in a patient with primary CNS lymphoma: A case report}, volume={4}, url={https://www.mjhid.org/mjhid/article/view/2012.020}, DOI={10.4084/mjhid.2012.020}, abstractNote={<p>Methotrexate is an antimetabolite commonly used in clinical practice for a variety of indications ranging from rheumatoid arthritis and other connective tissue disorders to high dose regimens in many malignancies. This folate antagonist has got a spectrum of toxicities among which gastrointestinal effects predominate . Lung injury is a well described but rare event and has been reported most often in patients who have been on long term oral therapy for rheumatic disorders. Acute lung injury in a patient receiving a high dose regimen for haematological malignancies has not been reported previously. We present one such case of methotrexate related acute lung injury in a patient of primary CNS lymphoma receiving high dose methotrexate.</p>}, number={1}, journal={Mediterranean Journal of Hematology and Infectious Diseases}, author={chhabra, puneet and dutt law, arjun and suri, dr vikas and malhotra, dr pankaj and varma, dr subhash}, year={2012}, month={Apr.}, pages={e2012020} }